| Korea | Health functional food | Strain identity, manufacturing process, heat-treatment conditions, and safety data required | Subject to MFDS review and approval | Inactivated cell counts, cell wall components |
| EU (EFSA) | Food / feed / additive | QPS-listed strains; no specific legal definition for postbiotics | Health claims require EFSA scientific substantiation | Process verification, indicator components |
| USA (FDA / FTC) | Food / dietary supplement / GRAS | GRAS status based on strain identity and manufacturing process | Claims must be scientifically substantiated; advertising overseen by the FTC | Strain identity, compositional markers |
| Canada | Natural health product (NHP) | Product-specific safety and efficacy data required | Claims reviewed by Health Canada | Strain and product characterization |
| Japan (MHLW) | Foods with function claims / supplements | Scientific evidence required for safety assessment | Claims require regulatory review | Strain identity, indicator markers |